Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine

Author： Mouton C. Calderon J. Janvier G. Vergnes M.-C.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.111, Iss.4, 2003-01, pp. : 273-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients

By Zambruni A. Thalheimer U. Coppell J. Riddell A. Mancuso A. Leandro G. Perry D. Burroughs A. K.

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 830-836

Informa Healthcare

Access to resources Recommend Favorite

Heparin-Binding Exosite of Factor Xa

By Rezaie A.R.

Trends in Cardiovascular Medicine, Vol. 10, Iss. 8, 2000-11 ,pp. : 333-338

Elsevier

Access to resources Recommend Favorite

A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents

By Mahan Charles

Journal of Thrombosis and Thrombolysis, Vol. 37, Iss. 3, 2014-04 ,pp. : 271-278

Springer Publishing Company

Access to resources Recommend Favorite

Magnetic Bead Protamine-Linked Microtiter Assay for Detection of Heparin using Iodinated Low-Molecular-Mass Heparin-Tyramine

By Harenberg J. Lohr G. Malsch R. Heene D.L. Guerrini M. Torri G. Casu B.

Thrombosis Research, Vol. 79, Iss. 2, 1995-07 ,pp. : 207-216

Elsevier

Access to resources Recommend Favorite

Reduction of Factor FVIIa Activity During Heparin Therapy - Evidence for Assay Interactions with Tissue Factor Pathway Inhibitor and Antithrombin

By Hansen J.-B. Svensson B. Sandset P.M. Thijssen F.

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite